Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q2 2018 · 10-Q
Revenue$152.23K$152.23K— vs Q2 2017 Net Income-$188.59K-$188.59KN/M vs Q2 2017 EPS Diluted$0.00$0.00— vs Q2 2017 Operating Income-$152,926N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$64,088N/M Margins · derivedOperating margin-100.5%
Net margin-123.9%
ended Jun 30, 2018 · filed Aug 10, 2018 · 41 d after period end